Light-Based scanner could help surgeons remove all cancer in one go

NCT ID NCT07459062

Recruiting now Diagnosis Sponsor: SPCTR Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new device called SPCTRone that uses light to analyze tissue during breast cancer surgery. The goal is to see if it can accurately tell surgeons whether all cancer has been removed, right in the operating room. About 100 women having breast-conserving surgery will take part, and the device's results will be compared to standard lab tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SPCTRone system (a device that uses light to analyze tissue)
What this could lead to: If successful, this could give surgeons real-time feedback during breast cancer surgery, reducing the need for second operations.
What could go wrong: This is an early feasibility study with only 100 participants. The device is still being trained and may not yet be accurate enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER MARGIN ASSESSMENT

Contacts and locations

Locations

Martini Ziekenhuis
RECRUITING

Groningen, Provincie Groningen, 9728NT, Netherlands
UMC Utrecht
NOT_YET_RECRUITING

Utrecht, Utrecht, 3584CX, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.